Pre-exposure Prophylaxis
Pre-Exposure Prophylaxis is a biomedical HIV prevention strategy involving the administration of antiretroviral medications to HIV-negative individuals prior to potential exposure to the virus in order to reduce the risk of acquisition.
2.8K
Publications
163.3K
Citations
12.5K
Authors
2.6K
Institutions
Publications per year
2017–2026
1.8K
Variants
Prep
Parents
Children
Biomedical Pre-exposure ProphylaxisDaily Oral Pre-exposure ProphylaxisEvent-driven Pre-exposure ProphylaxisLong-acting Injectable Pre-exposure ProphylaxisOn-demand Pre-exposure ProphylaxisPre-exposure Prophylaxis AcceptabilityPre-exposure Prophylaxis AccessPre-exposure Prophylaxis AdherencePre-exposure Prophylaxis Among Cisgender WomenPre-exposure Prophylaxis Among People Who Inject Drugs
2.8K
1–5 of 2.8K
12.5K
61
h-index
53
h-index
47
h-index
46
h-index
42
h-index
1–5 of 12.5K
2.6K
University of California, San Francisco
San Francisco, United States
73 h-index
719 publications
101.3K citations
Harvard University
Cambridge, United States
65 h-index
413 publications
36.3K citations
University of Washington
Seattle, United States
64 h-index
1.2K publications
76.1K citations

Fenway Health
Boston, United States
61 h-index
333 publications
32.4K citations

Johns Hopkins University
Baltimore, United States
57 h-index
687 publications
45.5K citations
San Francisco Department of Public Health
San Francisco, United States
56 h-index
244 publications
41.5K citations
Brown University
Providence, United States
51 h-index
470 publications
27.8K citations

Centers for Disease Control and Prevention
Atlanta, United States
48 h-index
649 publications
39.5K citations
1–8 of 2.6K
155 publications · 9K citations
58
h-index
210 publications · 11.5K citations
58
h-index
173 publications · 9K citations
55
h-index
JIAS · 158 publications · 8K citations
53
h-index
CID · 92 publications · 6.1K citations
45
h-index
1–5